Refine your search
Availability
-
Authors
- Adang, E M
- Barentsz, J O
- Beijnen, J H
- Büller, H R
- Frederix, G W
- Frederix, G W J
- Heesakkers, R A M
- Hoekman, J
- Hoogeveen, Y L
- Hooiveld, M J J
- Hövels, A M
- Jager, G J
- Leufkens, H G M
- Lipska, I
- Maitland-van der Zee, A H
- Mantel-Teeuwisse, A K
- Raaijmakers, J A M
- Schellens, J H M
- Severens, J L
- van Hasselt, J G C
- Show more
- Show less
-
Topics
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents
- Antineoplastic Agents, Hormonal
- Belgium
- Breast Neoplasms
- Chemotherapy, Adjuvant
- Cost-Benefit Analysis
- Decision Making
- Delivery of Health Care
- Disease Progression
- Disease-Free Survival
- Drug Approval
- Female
- Humans
- Middle Aged
- Receptor, ErbB-2
- diagnosis
- economics
- Show more
- Show less
-
Languages